{
  "test_metadata": {
    "timestamp": "2025-11-03T14:58:50.885585",
    "total_questions": 3,
    "total_time": 36.01426076889038,
    "avg_time_per_question": 12.004753589630127
  },
  "results": [
    {
      "question": "What is the effectiveness of thrombopoietin receptor agonists for preventing chemotherapy-induced thrombocytopenia in patients with solid tumours?",
      "question_num": 1,
      "category": "treatment_effectiveness",
      "success": true,
      "answer": "Based on the provided sources, there is no direct evidence available regarding the effectiveness of thrombopoietin receptor agonists for preventing chemotherapy-induced thrombocytopenia in patients with solid tumors. The summaries and analyses provided in the sources focus on various interventions and outcomes related to venous thrombo-embolic events in pediatric cancer patients with tunnelled central venous catheters[1][2], treatments for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura[3][4], the effects of chemoradiotherapy for cervical cancer[5][6], the use of colony-stimulating factors in patients with acute myelogenous leukemia[7], and the impact of chemotherapy with cetuximab versus chemotherapy alone for advanced non-small cell lung cancer[8][9]. Additionally, there is information on interval debulking surgery for advanced epithelial ovarian cancer[10].\n\nNone of these sources directly address the question of thrombopoietin receptor agonists' effectiveness in preventing chemotherapy-induced thrombocytopenia in patients with solid tumors. Therefore, based on the evidence provided, it is not possible to make a claim or provide an evidence-based answer regarding the effectiveness of thrombopoietin receptor agonists for this specific purpose. Further research and targeted systematic reviews would be necessary to gather evidence on this topic and to provide a conclusive answer.",
      "num_sources": 10,
      "sources": [
        {
          "index": 1,
          "title": "Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009160.pub2/full",
          "doi": "10.1002/14651858.CD009160.pub2",
          "section": "results",
          "topic": "Child health",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.8760810494422913
        },
        {
          "index": 2,
          "title": "Systemic treatments for the prevention of venous thrombo‐embolic events in paediatric cancer patients with tunnelled central venous catheters",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009160.pub2/full",
          "doi": "10.1002/14651858.CD009160.pub2",
          "section": "results",
          "topic": "Child health",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.8760810494422913
        },
        {
          "index": 3,
          "title": "Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003595.pub2/full",
          "doi": "10.1002/14651858.CD003595.pub2",
          "section": "results",
          "topic": "Infectious disease",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.7447682619094849
        },
        {
          "index": 4,
          "title": "Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003595.pub2/full",
          "doi": "10.1002/14651858.CD003595.pub2",
          "section": "results",
          "topic": "Infectious disease",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.7447682619094849
        },
        {
          "index": 5,
          "title": "Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta‐analysis",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008285/full",
          "doi": "10.1002/14651858.CD008285",
          "section": "results",
          "topic": "Cancer",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.7217498421669006
        },
        {
          "index": 6,
          "title": "Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta‐analysis",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008285/full",
          "doi": "10.1002/14651858.CD008285",
          "section": "results",
          "topic": "Cancer",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.7197652459144592
        },
        {
          "index": 7,
          "title": "Colony‐stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008238.pub3/full",
          "doi": "10.1002/14651858.CD008238.pub3",
          "section": "results",
          "topic": "Cancer",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.6242009997367859
        },
        {
          "index": 8,
          "title": "Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy‐naive advanced non‐small cell lung cancer",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009948.pub2/full",
          "doi": "10.1002/14651858.CD009948.pub2",
          "section": "results",
          "topic": "Lungs & airways",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.5750337839126587
        },
        {
          "index": 9,
          "title": "Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy‐naive advanced non‐small cell lung cancer",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009948.pub2/full",
          "doi": "10.1002/14651858.CD009948.pub2",
          "section": "results",
          "topic": "Lungs & airways",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.5749474763870239
        },
        {
          "index": 10,
          "title": "Interval debulking surgery for advanced epithelial ovarian cancer",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006014.pub7/full",
          "doi": "10.1002/14651858.CD006014.pub7",
          "section": "results",
          "topic": "Gynaecology",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.5717102885246277
        }
      ],
      "quality_summary": "Grade A: 10",
      "statistical_summary": "All 10 sources contain statistical data",
      "retrieval_time": 12.533403158187866,
      "error": null
    },
    {
      "question": "How effective are pathogen-reduced platelets compared to standard platelets for preventing bleeding?",
      "question_num": 2,
      "category": "treatment_effectiveness",
      "success": true,
      "answer": "I'm sorry, but there is no direct evidence provided in the sources regarding the effectiveness of pathogen-reduced platelets compared to standard platelets for preventing bleeding. The information available focuses on other aspects of blood transfusion and treatment for specific conditions such as thrombotic thrombocytopenic purpura (TTP) and haemolytic uraemic syndrome (HUS), as well as the effects of leukoreduction in blood transfusion and the use of antiplatelet and anticoagulation therapy in patients with prosthetic heart valves[1][3][7]. For accurate and evidence-based information on the effectiveness of pathogen-reduced platelets compared to standard platelets for preventing bleeding, a review of literature specifically addressing this question would be required.",
      "num_sources": 7,
      "sources": [
        {
          "index": 1,
          "title": "Antiplatelet and anticoagulation for patients with prosthetic heart valves",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003464.pub2/full",
          "doi": "10.1002/14651858.CD003464.pub2",
          "section": "results",
          "topic": "Child health",
          "quality_grade": "A",
          "is_statistical": true,
          "relevance_score": 0.8062804341316223
        },
        {
          "index": 2,
          "title": "Antiplatelet and anticoagulation for patients with prosthetic heart valves",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003464.pub2/full",
          "doi": "10.1002/14651858.CD003464.pub2",
          "section": "results",
          "topic": "Child health",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.8062804341316223
        },
        {
          "index": 3,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.7872937321662903
        },
        {
          "index": 4,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.699999988079071
        },
        {
          "index": 5,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.5046994090080261
        },
        {
          "index": 6,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.5038533210754395
        },
        {
          "index": 7,
          "title": "Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003595.pub2/full",
          "doi": "10.1002/14651858.CD003595.pub2",
          "section": "results",
          "topic": "Infectious disease",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.49348196387290955
        }
      ],
      "quality_summary": "Grade A: 7",
      "statistical_summary": "1 of 7 sources contain statistical data",
      "retrieval_time": 11.153470993041992,
      "error": null
    },
    {
      "question": "What are the benefits and risks of restrictive versus liberal red blood cell transfusion strategies in patients with haematological malignancies?",
      "question_num": 3,
      "category": "treatment_effectiveness",
      "success": true,
      "answer": "Based on the provided excerpts, there is no direct evidence from Cochrane systematic reviews specifically addressing the benefits and risks of restrictive versus liberal red blood cell transfusion strategies in patients with hematological malignancies. The excerpts focus on leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion[1][2][3][4][5] and stem cell-based interventions for the prevention and treatment of intraventricular hemorrhage and encephalopathy of prematurity in preterm infants[6], which do not directly relate to the question about transfusion strategies in patients with hematological malignancies.\n\nTherefore, to answer questions regarding the benefits and risks of restrictive versus liberal red blood cell transfusion strategies in patients with hematological malignancies, a search for systematic reviews or clinical trials specifically examining these transfusion strategies in this patient population would be necessary. Without direct evidence from the provided Cochrane systematic reviews, it is not possible to provide an evidence-based answer to this question.",
      "num_sources": 6,
      "sources": [
        {
          "index": 1,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.7166780233383179
        },
        {
          "index": 2,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.7154595255851746
        },
        {
          "index": 3,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.699999988079071
        },
        {
          "index": 4,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.6889193654060364
        },
        {
          "index": 5,
          "title": "Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009745.pub2/full",
          "doi": "10.1002/14651858.CD009745.pub2",
          "section": "results",
          "topic": "Allergy & intolerance",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.6423107981681824
        },
        {
          "index": 6,
          "title": "Stem cell‐based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants",
          "url": "https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013201.pub3/full",
          "doi": "10.1002/14651858.CD013201.pub3",
          "section": "results",
          "topic": "Neonatal care",
          "quality_grade": "A",
          "is_statistical": false,
          "relevance_score": 0.5654516220092773
        }
      ],
      "quality_summary": "Grade A: 6",
      "statistical_summary": "No statistical data available",
      "retrieval_time": 12.327292919158936,
      "error": null
    }
  ],
  "summary": {
    "total_tested": 3,
    "successful": 3,
    "failed": 0,
    "success_rate": 100.0,
    "average_sources_per_question": 7.666666666666667,
    "average_retrieval_time": 12.004722356796265,
    "total_time_seconds": 36.01426076889038,
    "results_by_category": {
      "treatment_effectiveness": {
        "total": 3,
        "successful": 3,
        "failed": 0
      }
    }
  }
}